ITeos Therapeutics Inc (ITOS) USD0.001
Sell:$10.16Buy:$10.24
$0.02
(0.20%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$10.16
Buy:$10.24
Change:$0.02
(0.20%)
$0.02
(0.20%)Prices delayed by at least 15 minutes
Sell:$10.16
Buy:$10.24
Change:$0.02
(0.20%)
$0.02
(0.20%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 10 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 8,400 | $10.02 | $84,168.00 | 135,903 |
| 10 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 43,883 | $10.02 | $439,707.66 | 0 |
| 9 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 8,400 | $10.03 | $84,252.00 | 135,903 |
| 9 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 43,882 | $10.03 | $440,136.46 | 0 |
| 6 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 8,400 | $10.21 | $85,764.00 | 135,903 |
| 6 June 2025 | David L. HallalChairman of the Board | Sell Option/Award related | 38,228 | $10.24 | $391,454.72 | 0 |
| 6 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 43,882 | $10.21 | $448,035.22 | 0 |
| 5 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 8,400 | $10.15 | $85,260.00 | 135,903 |
| 5 June 2025 | David L. HallalChairman of the Board | Sell Option/Award related | 38,227 | $10.15 | $388,004.05 | 0 |
| 5 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 43,882 | $10.15 | $445,402.30 | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 May 2025 | ECOR1 CAPITAL LLCInvestment Fund | Buy Regular purchase transaction | 3,300,000 | $8.00 | $26,400,000.00 | 10,688,978 |
| 14 May 2025 | ECOR1 CAPITAL LLCInvestment Fund | Buy Regular purchase transaction | 1,658,978 | $7.41 | $12,285,561.58 | 7,388,978 |
| 13 May 2025 | UBS ONCOLOGY IMPACT FUND LPVenture Capital | Sell Regular sell transaction (market) | 1,031,931 | $8.06 | $8,317,363.86 | 3,452,797 |
| 13 May 2025 | MPM BIOVENTURES 2014 LPVenture Capital | Sell Regular sell transaction (market) | 630,191 | $8.06 | $5,079,339.46 | 2,108,594 |
| 6 June 2025 | Michel DetheuxChairman/CEO | Sell Option/Award related | 43,882 | $10.21 | $448,035.22 | 0 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.